Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level
Aim. The aim of our study was to continue a comparative analysis of availability and access to cardiovascular medicines in 2017 and 2018 in the city of Kazan according to the original WHO/HAI methodology to assess the effectiveness of government interventions to ensure access to medicines.Material a...
Main Authors: | C. M. Razzakova, L. E. Ziganshina |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2020-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/2326 |
Similar Items
-
Cardiovascular medicine prices as an indicator of access to medicines and their rational use
by: C M. Razzakova, et al.
Published: (2019-05-01) -
Medicine prices in 2017 and 2018 as a reflection of the effectiveness of government measures to ensure access to medicines
by: C M Razzakova, et al.
Published: (2020-04-01) -
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
by: Mekonnen Sisay, et al.
Published: (2021-07-01) -
Prices of medicines for the management of pain, diabetes and cardiovascular diseases in private pharmacies and the national health insurance in Tanzania
by: Rashid Bakari Kirua, et al.
Published: (2020-11-01) -
How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014
by: NM Hamzah, et al.
Published: (2020-06-01)